The fight against breast cancer continues with the "The future needs time" campaign
In the month dedicated to the fight against breast cancer, "The future needs time" kicks off, the national awareness campaign on the topic that bears the signature of alfemminile.com with the unconditional contribution of Roche, aimed at spreading scale a culture of prevention and early diagnosis to defeat the number one enemy of women.
With this in mind, Wednesday 29 October, from 6 to 7 pm, at the Auditorium Del Teatro Carlo Felice in Genoa, there will be a free meeting open to the public in which Professor Paolo Pronzato and Doctor Lucia Del Mastro, of the National Institute for Cancer Research of Genoa, which will address the delicate issue at 360 °: from correct information, to prevention, from early diagnosis to the therapeutic path.
Breast cancer unfortunately still represents a pathology that shows no signs of stopping its course, especially due to the incidence that in women of relatively young age, less than 45 years, has increased. In fact, there are 400,000 cases in Italy alone with an incidence of about 45,000 new cases per year (about 140 per 100,000 inhabitants). It is mainly women who live in the north of Italy who get sick, although in the south still very few of them undergo routine diagnostic tests such as mammography or ultrasound. Every year 1,200 new cases are recorded throughout Liguria, of which 400 in Genoa alone. "Although the numbers are still so high, healings are increasing thanks to early diagnosis and the availability of new and increasingly effective therapies that allow the treatment of even the most aggressive forms of this pathology, such as HER2-positive tumors, which can be observed in about one in five cases of breast cancer. In the last 20-30 years, thanks to mammography and ultrasound screenings, conservative surgical therapies, less toxic chemotherapies, biological drugs, we have witnessed a constant decline in the mortality curve in HER2 positive breast cancer, one of the most aggressive forms " , explains Paolo Pronzato, Director of Medical Oncology at IRCCS AOU San Martino, IST National Institute for Cancer Research in Genoa.
In fact, 9 out of 10 patients diagnosed with breast cancer survive the disease thanks to the correct diagnostic-therapeutic process; and it is precisely with this in mind and to take ever more steps forward in the world of prevention and research that the “The future needs time” campaign was conceived, promoted by alfemminile.com and supported by Roche."This campaign is a way to raise awareness among women on the subject and to encourage a dialogue on the approach to the disease, as well as on prevention", declares Maria Cecilia Andretta, CEO of alfemminile.com, who continues: "But also to inform them , through the voice of specialists, of the progress made by science in the fight against this neoplasm, with the aim of making them feel less alone, also by sharing many common experiences in our forum. We believe that the more women will have the clear ideas about this pathology, the more we will have contributed to developing a culture of prevention and early diagnosis that can really save lives. For this reason, we also asked Salute Donna to participate in this campaign by dedicating a space to it on our website. only through collaboration with a group of people who are familiar with the big and small problems a woman faces when receiving a diagnosis of cancer and, we can really do our part too. "
For this reason, as part of the Campaign, special contents relating to breast cancer are dedicated throughout the year on www.alfemminile.com/ilfuturohabisognoditempo, starting with the importance of prevention. Regarding secondary prevention, mammography is the most suitable diagnostic tool for correct early diagnosis. According to the most recent studies, breast cancer mortality is reduced by about 35% among women who practice mammography every two years, although in our country there are still considerable geographical inequalities regarding participation in collective screening campaigns.